Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 444-040-0 | CAS number: 52950-18-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP Guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 003
- Report date:
- 2003
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Principles of method if other than guideline:
- The study was performed to assess the acute toxicity following oral administration of (R)-2-Chlormandelsäure in Wistar rats.
The study procedure was based on the OECD, EU and US EPA OPPTS guidelines. - GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- yes
Test material
- Reference substance name:
- (2R)-2-(2-chlorophenyl)-2-hydroxyethanoic acid
- EC Number:
- 444-040-0
- EC Name:
- (2R)-2-(2-chlorophenyl)-2-hydroxyethanoic acid
- Cas Number:
- 52950-18-2
- Molecular formula:
- Hill formula: C8H7ClO3 CAS formula: C8H7CLO3
- IUPAC Name:
- (2R)-2-(2-chlorophenyl)-2-hydroxyacetic acid
- Details on test material:
- - Name of test material (as cited in study report): (R)-2-chloromandelic acid; Substance No.: 01/0490-1
- Physical state: Solid (crystalline) / white to slight yellowish
- Analytical purity: 99.7 area-%
- Impurities (identity and concentrations):
- Date of Production: February 07, 2002
- Lot/batch No.: T138-02-01
- Storage condition of test material: Room temperature
- Homogeneity: Homogeneous by visual inspection
- Stability: The stability under storage conditions over the exposure period was guaranteed by the sponsor.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Deutschland GmbH, Sandhofer Weg 7, 97633 Sulzfeld
- Age at study initiation: Young adult animals (male animals approx. 8 - 12 weeks, female animals approx. 14-18 weeks)
- Weight at study initiation: Animals of comparable weight (± 20% of the mean weight)
- Fasting period before study: Feed was withdrawn from the animals at least 16 hours before administration, but water was available ad libitum.
- Housing: Single housing
- Diet: Kliba-Labordiät, Provimi Kuba SA, Kaiseraugst, Switzerland, ad libitum
- Water: Tap water ad libitum
- Acclimation period: for at least 1 week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24
- Humidity (%): 30-70
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: test substance in 0.5% carboymethylcellulose solution in doubly distilled water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 20 g/100 ml
MAXIMUM DOSE VOLUME APPLIED: 10 ml/kg
DOSAGE PREPARATION:
The test substance preparation was produced for each administration group shortly before administration in 0.5% CMC-solution (cleaned sodium carboxymethylcellulose, Hoechst AG) in doubly distilled water by stirring with high speed homogenizer (Ultra-Turrax).
- Doses:
- 2000 mg/kg
- No. of animals per sex per dose:
- 3 male and 3 female animals
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: daily
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight
Body weight determination:
Individual body weights shortly before administration (day 0), weekly thereafter and at the end of the study. Additionally, at day of death in animals that died starting with study day 1.
Signs and symptoms:
Recording of signs and symptoms several times on the day of administration, at least once each workday for the individual animals; these records are maintained with the raw data.
Mortality:
A check for any dead or moribund animal was made twice each workday and once on Saturdays, Sundays and on public holidays.
Pathology:
Necropsy with gross-pathology examination on the last day of the observation period after killing with CO2. Necropsy of all animals that died before as early as possible.
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Mortality:
- One female animal was found dead on study day 1. No mortality occurred in the male animals.
- Clinical signs:
- Male animal symptoms
Clinical observation revealed impaired general state, dyspnoea, smeared fur and were observed from hour 2 until including study day 2 after administration.
Female animal symptoms
Clinical observation revealed impaired and poor general state, dyspnoea, staggering, piloerection, smeared fur, red clammy snout and were observed from hour 0 until including study day 1 after administration. - Body weight:
- The mean body weights of the male animals increased throughout the study period. The mean body weights of the female animals increased during the first post exposure observation week but decreased during the second week.
- Gross pathology:
- The following macroscopic pathologic abnormality was observed in the animal that was found dead (1 female): lesion on the mucosal membrane of the glandular stomach with necrotizing surface. No macroscopic pathologic abnormalities were noted in the animals (3 males and 2 females) examined at termination of the study.
Any other information on results incl. tables
ANALYSES
Analysis of test substance:
The stability of the test substance in the vehicle for the preparations: maximum application period was confirmed indirectly by analysis of homogeneity analysis of the concentration. The correctness of the homogeneity of the test substance preparation for the first administration was confirmed by analysis.
Conduct of analyses:
The analyses were carried out at the Analytical Chemistry Laboratory of the Experimental Toxicology and Ecology of BASF AG.
Analysis of feed:
In view of the aim and duration of the study the contaminants occurring in commercial feed should not influence the results.
Analysis of drinking water:
In view of the aim and duration of the study there are no special requirements exceeding the specification of drinking water.
CONCLUSION
Under the conditions of this study the median lethal dose of the test substance after oral administration was found to be greater than 2,000 mg/kg body weight for male and female rats.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.